Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 10501731 Degradable clostridial toxins

Patent 10501731 was granted and assigned to Allergan, Inc. on December, 2019 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Current Assignee
Allergan, Inc.
Allergan, Inc.
0
Date Filed
December 18, 2017
0
Date of Patent
December 10, 2019
0
Patent Applicant
Allergan, Inc.
Allergan, Inc.
0
Patent Application Number
15845572
0
Patent Citations Received
‌
US Patent 11833185 Anti-neurodegenerative therapeutic, method of manufacture, and use
0
‌
US Patent 11248218 Botulinum neurotoxin and its derivatives
‌
US Patent 11286473 Botulinum neurotoxin and its derivatives
0
‌
US Patent 11707510 Nucleic acid-based botulinum neurotoxin for therapeutic use
0
‌
US Patent 11434265 Chimeric neurotoxins
0
Patent Inventor Names
Sanjiv Ghanshani
0
Ester Fernandez-Salas
0
Joseph Francis
0
Kei Roger Aoki
0
Lance E. Steward
0
Marcella A. Gilmore
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
10501731
0
Patent Primary Examiner
‌
Iqbal H Chowdhury
0

Find more entities like US Patent 10501731 Degradable clostridial toxins

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.